A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic Hyperuricemia
Clinical trial NCT05302388 · COMPLETED
Trial details
- NCT number
- NCT05302388
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2023-01-09
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.